Category: Company News
-

IM Cannabis Agrees European Asset Sale as Transaction Targets C$3 Million Equity Improvement
IM Cannabis (NASDAQ:IMCC) has entered into a definitive agreement to sell IMC Holdings and its European-focused assets to Slil.com Holding, a transaction management expects to improve shareholders’ equity by approximately C$3 million while reducing liabilities and simplifying the company’s structure. The proposed European asset sale would leave IM Cannabis focused on its Israeli medical cannabis…
-

Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances
Glucotrack (NASDAQ:GCTK) has regained compliance with Nasdaq’s stockholders’ equity requirement, with the Nasdaq Hearings Panel granting the company’s request for continued listing subject to certain conditions. The Nasdaq compliance milestone removes one specific listing issue for Glucotrack as management continues its strategic transformation, although the company said it is still working toward full compliance with…
-

HIVE Signs $350 Million AI Cloud Services Agreement as BUZZ HPC Expands Contracted Revenue
HIVE Digital Technologies (NASDAQ:HIVE) has secured a $350 million AI cloud services agreement through its BUZZ HPC subsidiary, adding about $70 million in annualized revenue under a five-year contract with an investment-grade enterprise customer. The deal increases BUZZ HPC’s total annualized revenue to approximately $180 million and commits HIVE to deploying a new 2,016-GPU AI…
-

American Fusion Appoints Strategic Advisor to Support Texatron Commercialization and European Expansion
American Fusion has appointed Niclas von Schantz as Strategic Advisor for brand strategy, commercialization and international market development, adding commercial expertise as the company advances engineering and testing of its Texatron Fusion Engine. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion is adding commercialization and international market-development expertise to its Texatron Fusion…
-

Victory Marine Holdings Appoints E-Commerce Director to Scale GUTSI Omnichannel Growth
Victory Marine Holdings has appointed Miles Bodie as Director of E-Commerce at its Dunn & Groux Beverage Holdings subsidiary, adding dedicated leadership to expand GUTSI across Amazon, Walmart Marketplace and direct-to-consumer channels. Key Investor Takeaways Why VMHG Stock Is in Focus Victory Marine’s DGBH subsidiary has appointed Bodie to lead the next phase of its…
-

Netlist Files Patent Infringement Action Against Micron at U.S. International Trade Commission
Netlist has launched new patent infringement proceedings against Micron and other technology companies at the U.S. International Trade Commission, seeking orders that could block allegedly infringing memory products from entering the United States. The company has also filed a separate patent lawsuit against Micron in federal court in California. Key Investor Takeaways Why (USOTC:NLST) Stock…
-

BioAdaptives Launches XcellaraHeart With Pre-Orders Ahead of August 26 Shipments
BioAdaptives has commercially launched XcellaraHeart, opening pre-orders for the flagship product in its seven-formula Xcellara cellular wellness platform, with the first commercial batch scheduled to ship on August 26, 2026. Key Investor Takeaways Why BDPT Stock Is in Focus BioAdaptives has officially launched XcellaraHeart, shifting its Xcellara cellular wellness strategy into the commercial stage. Limited…
-

Cardiff Lexington H1 Revenue Declines as Working Capital Constraints Pressure Performance
Cardiff Lexington reported lower year-to-date revenue and a near-breakeven adjusted EBITDA result for the first half of 2026, as weaker realization rates on patient case settlements and working capital constraints offset growth in new patients and surgical procedures. Key Investor Takeaways Why CDIX Stock Is in Focus Cardiff Lexington’s second-quarter filing highlights a divergence between…
-

Valion Bio Advances Government-Funded Entolimod Radiation Injury Studies With Data Expected in Early Fall
Valion Bio is moving into a near-term government-funded Entolimod study programme evaluating protection against lethal radiation-induced gastrointestinal injury, with safety dosing planned to begin this week and top-line therapeutic data anticipated in early fall. Key Investor Takeaways Why VBIO Stock Is in Focus Valion Bio’s Entolimod programme is approaching an important experimental stage as AFRRI…
-

Capstone Q2 Revenue Jumps 67% as Stone Business Adjusted EBITDA Turns Positive
Capstone Holding reported 67% year-over-year revenue growth in the second quarter of 2026, while Stone Business Adjusted EBITDA reached $2.0 million and turned positive sequentially as previously guided. The building products distributor also reaffirmed its full-year 2026 financial guidance. Key Investor Takeaways Why (NASDAQ:CAPS) Stock Is in Focus Capstone’s second-quarter results showed faster gross profit…